À§¾Ï °ËÁø ±Ç°í¾È
The Korean guideline for gastric cancer screening
´ëÇÑÀÇ»çÇùȸÁö 2015³â 58±Ç 5È£ p.373 ~ p.384
¹ÚÇö¾Æ(Park Hyun-Ah) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ¼¿ï¹éº´¿ø °¡Á¤ÀÇÇб³½Ç
³²¼ö¿¬(Nam Su-Youn) - °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ °æºÏ´ëÇб³º´¿ø ¼Òȱ⳻°ú
ÀÌ»ó±æ(Lee Sang-Kil) - ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¼¼ºê¶õ½ºº´¿ø ³»°úÇб³½Ç
±è»ó±Õ(Kim Sang-Gyun) - ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç, °£¿¬±¸¼Ò
½É±â³²(Shim Ki-Nam) - ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
¹Ú»ó¹Î(Park Sang-Min) - ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
À̼±¿µ(Lee Sun-Young) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ³»°úÇб³½Ç
ÇÑÇý½Â(Han Hye-Seung) - °Ç±¹´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø º´¸®Çб³½Ç
½Å¿ë¹®(Shin Yong-Moon) - ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼¿ï¾Æ»êº´¿ø ¿µ»óÀÇÇаú±³½Ç
±è°æ¹Ì(Kim Kyoung-Mee) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌ°æÀç(Lee Kyung-Jae) - ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ¼øõÇâ´ëÇÐ ¼¿ïº´¿ø Á÷¾÷ȯ°æÀÇÇаú
ÀÌÅ¿ë(Lee Tae-Yong) - Ãæ³²´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¿¹¹æÀÇÇб³½Ç
ÃÖÀÏÁÖ(Choi Il-Ju) - ±¹¸³¾Ï¼¾ÅÍ À§¾Ï¼¾ÅÍ
È«¼º¼÷(Hong Seong-Sook) - ¼øõÇâ´ëÇб³ ¼¿ïº´¿ø ¿µ»óÀÇÇаú
±èÀç¿ì(Kim Jae-Woo) - ±¹¸³¾Ï¼¾ÅÍ ¾Ï°ËÁø»ç¾÷°ú
ÀÌÀ±Àç(Lee Yoon-Jae) - ºÐ´çÂ÷Çѹ溴¿ø ÇѹæºÎÀΰú
±è¼ö¿µ(Kim Soo-Young) - ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ °µ¿¼º½Éº´¿ø °¡Á¤ÀÇÇаú
±è¿(Kim Yeol) - ±¹¸³¾Ï¼¾ÅÍ ¾Ï°ËÁø»ç¾÷°ú
ÀÌ¿øö(Lee Won-Chul) - °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
Á¤ÀϱÇ(Chung Il-Kwun) - ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇРõ¾Èº´¿ø ³»°úÇб³½Ç
Abstract
Despite improvements in treatment modalities, gastric cancer is the second cause of mortality among Korean men and third among females in Korea. Korea implemented a gastric cancer screening program for the general population in 1999. However, the effectiveness and harms of gastric cancer screening using gastric endoscopy and upper gastrointestinal (UGI) series have not been fully evaluated. In an effort to evaluate the screening program, the Korean multidisciplinary expert committee for developing a gastric cancer screening guideline systematically reviewed the evidence regarding the benefits and harms of gastric cancer screening, and developed an evidence-based clinical guideline. There is ¡®low¡¯ level evidence that gastric cancer screening using gastric endoscopy or UGI series can reduce gastric cancer mortality for asymptomatic adults aged between 40 to 74 years. The benefits of gastric cancer screening using gastric endoscopy are substantially higher than its harms, while the benefits of screening with UGI series are moderately higher. We recommend that asymptomatic adults from 40 to 75 years of age undergo biannual gastric cancer screening using gastric endoscopy (recommendation B). Gastric cancer screening using UGI series in asymptomatic adults aged between 40 to 74 years may be recommended based on clinicians¡¯ judgment regarding the patient¡¯s risk and the patient¡¯s preference (recommendation C). There is insufficient evidence to assess the benefits and harms of gastric cancer screening for adults aged between 75 to 84 years (recommendation I). We recommend against gastric cancer screening for adults older than 85 years (recommendation D).
Å°¿öµå
Early detection of cancer, Gastric neoplasms, Guideline, Gastric endoscopy, Upper gastrointestinal series
KMID :
0614720150580050373
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
40-74¼¼ ¹«Áõ»ó ¼ºÀÎÀ» ´ë»óÀ¸·Î À§³»½Ã°æ°ú À§ÀåÁ¶¿µ ÃÔ¿µÀ» ÀÌ¿ëÇÑ À§¾Ï°ËÁøÀÌ À§¾Ï»ç¸Á·üÀ» °¨¼Ò½Ãų ¼ö ÀÖ´Ù